6501 - 6510 of 6516 Results
Title
Year
-
OPENTitle: Open science takes on Parkinson’s diseaseJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.66546Best OA location URL: https://doi.org/10.7554/elife.66546Citation Count: 27
-
OPENTitle: Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2Journal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 11Issue #: 23Start Page: eadt2050End Page: eadt2050Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adt2050Best OA location URL: https://doi.org/10.1126/sciadv.adt2050Citation Count: 14
-
OPENTitle: Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson’s disease modelsJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 3Issue #: 3-4Start Page: 194End Page: 208Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1242/dmm.004267Best OA location URL: http://doi.org/10.1242/dmm.004267Citation Count: 175
-
OPENTitle: From policy to practice: Lessons learned from an open science funding initiativeJournal Name: PLOS Computational BiologyPublisher: Public Library of Science (PLoS)Vol: 19Issue #: 12Start Page: e1011626End Page: e1011626Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1371/journal.pcbi.1011626Best OA location URL: https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1011626&type=printableCitation Count: 4
-
OPENTitle: α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicityJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 41Issue #: 3Start Page: 308End Page: 315Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ng.300Best OA location URL: http://doi.org/10.1038/ng.300Citation Count: 536
- LINE-1 retrotransposons drive human neuronal transcriptome complexity and functional diversification2023OPENTitle: LINE-1 retrotransposons drive human neuronal transcriptome complexity and functional diversificationJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 44Start Page: eadh9543End Page: eadh9543Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adh9543Best OA location URL: https://doi.org/10.1126/sciadv.adh9543Citation Count: 64
-
OPENTitle: Use of Glycolysis‐Enhancing Drugs and Risk of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2210End Page: 2216Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29184Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29184Citation Count: 28
-
OPENTitle: Rapid selection of cyclic peptides that reduce α-synuclein toxicity in yeast and animal modelsJournal Name: Nature Chemical BiologyPublisher: Springer Science and Business Media LLCVol: 5Issue #: 9Start Page: 655End Page: 663Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nchembio.193Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2729362Citation Count: 137
-
OPENTitle: Hsp104 antagonizes α-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson diseaseJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 118Issue #: 9Start Page: 3087End Page: 3097Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci35781Best OA location URL: http://www.jci.org/articles/view/35781/files/pdfCitation Count: 195
-
OPENTitle: Pitx3 is required for development of substantia nigra dopaminergic neuronsJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 100Issue #: 7Start Page: 4245End Page: 4250Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.0230529100Best OA location URL: http://doi.org/10.1073/pnas.0230529100Citation Count: 387